Transthyretin Amyloid Cardiomyopathy Treatment Market is Poised to Grow at an Impressive CAGR owing to Increasing Prevalence of ATTR-CM
The transthyretin amyloid cardiomyopathy treatment market comprises drugs indicated for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM), a rare and fatal condition caused by aggregation …